SEC Form 4 · accession 0001645627-17-000105
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Aug 10, 2017
Accepted (ET)
Aug 11, 2017 · 9:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 10, 2017 | P | 1,500 | $0.029 | A | 22,276,889 | D | |
| Common Stock | Aug 10, 2017 | P | 2,000 | $0.0289 | A | 22,278,889 | D | |
| Common Stock | Aug 10, 2017 | P | 5,000 | $0.0289 | A | 22,283,889 | D | |
| Common Stock | Aug 10, 2017 | P | 2,000 | $0.0288 | A | 22,285,889 | D | |
| Common Stock | Aug 10, 2017 | P | 2,000 | $0.0288 | A | 22,287,889 | D | |
| Common Stock | Aug 10, 2017 | P | 1,000 | $0.0288 | A | 22,288,889 | D | |
| Common Stock | Aug 10, 2017 | P | 1,000 | $0.0289 | A | 22,289,889 | D | |
| Common Stock | Aug 10, 2017 | P | 5,000 | $0.0289 | A | 22,294,889 | D | |
| Common Stock | Aug 10, 2017 | P | 5,000 | $0.0269 | A | 22,299,889 | D | |
| Common Stock | Aug 10, 2017 | P | 2,000 | $0.027 | A | 22,301,889 | D | |
| Common Stock | Aug 10, 2017 | P | 2,000 | $0.0269 | A | 22,303,889 | D | |
| Common Stock | Aug 10, 2017 | P | 2,000 | $0.027 | A | 22,305,889 | D |
Table II — derivative securities
No Table II lines on this filing.